Efficacy of first-line atezolizumab combination therapy in patients with non-small cell lung cancer receiving proton pump inhibitors: post hoc analysis of IMpower150
Ashley M. Hopkins, Ganessan Kichenadasse, Ross A. McKinnon, Ahmad Y. Abuhelwa, Jessica M. Logan, Sarah Badaoui, Christos S. Karapetis, Andrew Rowland, Michael J. Sorich
Topics & Concepts
AtezolizumabMedicineHazard ratioInternal medicineCarboplatinBevacizumabOncologyLung cancerPaclitaxelPost-hoc analysisCancerGastroenterologyChemotherapyNivolumabConfidence intervalImmunotherapyCisplatinGastroesophageal reflux and treatmentsCancer Immunotherapy and BiomarkersGut microbiota and health